Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
0.3751
-0.0379 (-9.18%)
At close: Sep 12, 2025, 4:00 PM EDT
0.3611
-0.0140 (-3.73%)
After-hours: Sep 12, 2025, 7:44 PM EDT
Biodesix Revenue
Biodesix had revenue of $20.02M in the quarter ending June 30, 2025, with 11.68% growth. This brings the company's revenue in the last twelve months to $76.56M, up 25.70% year-over-year. In the year 2024, Biodesix had annual revenue of $71.32M with 45.30% growth.
Revenue (ttm)
$76.56M
Revenue Growth
+25.70%
P/S Ratio
0.72
Revenue / Employee
$280,425
Employees
273
Market Cap
58.52M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 71.32M | 22.24M | 45.30% |
Dec 31, 2023 | 49.09M | 10.88M | 28.46% |
Dec 31, 2022 | 38.21M | -16.29M | -29.89% |
Dec 31, 2021 | 54.51M | 8.95M | 19.64% |
Dec 31, 2020 | 45.56M | 21.01M | 85.55% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
BDSX News
- 2 days ago - Biodesix Announces One-for-Twenty Reverse Stock Split - GlobeNewsWire
- 8 days ago - Biodesix to Participate in Lake Street Capital Markets' 9th Annual Best Ideas Growth (BIG9) Conference - GlobeNewsWire
- 24 days ago - Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics - GlobeNewsWire
- 4 weeks ago - Biodesix, Inc. (BDSX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Biodesix Announces Second Quarter 2025 Results and Highlights - GlobeNewsWire
- 5 weeks ago - Biodesix to Present at the Canaccord Genuity 45th Annual Growth Conference - GlobeNewsWire
- 7 weeks ago - Biodesix to Report Second Quarter 2025 Financial Results on August 7, 2025 - GlobeNewsWire
- 3 months ago - Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation's First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs - GlobeNewsWire